William Blair on Medline Inc (MDLN) Post Conference: 'Management reiterated the most recent FDA warning letter is isolated'
William Blair analyst Brandon Vazquez reiterated an Outperform rating and {REMOVEPT} price target on Medline Inc (NASDAQ: MDLN).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)